Insmed
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $425,486 | $305,964 | $263,843 | $142,342 |
Gross Profit | 358,274 | 256,463 | 219,623 | 112,977 |
EBITDA | 14,160 | -136,323 | -302,150 | -345,665 |
EBIT | 8,900 | -142,016 | -307,711 | -349,661 |
Net Income | -13,242 | -163,563 | -328,485 | -370,021 |
Net Change In Cash | 425,486 | 305,964 | 263,843 | 142,342 |
Free Cash Flow | -321,305 | -226,218 | -294,185 | -222,179 |
Cash | 544,765 | 582,188 | 510,445 | 334,764 |
Basic Shares | 217,352 | 215,468 | 213,637 | 211,441 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $606,423 | $363,707 | $305,208 | $245,358 |
Gross Profit | 481,548 | 277,965 | 239,635 | 190,232 |
EBITDA | -1,171,504 | -818,794 | -660,177 | -447,365 |
EBIT | -1,187,954 | -829,807 | -670,756 | -457,696 |
Net Income | -1,276,775 | -913,772 | -749,567 | -481,534 |
Net Change In Cash | 606,423 | 363,707 | 305,208 | 245,358 |
Cost of Revenue | 358,250 | |||
Free Cash Flow | -967,575 | -705,805 | -549,535 | -410,317 |
Cash | 510,445 | 555,030 | 482,374 | 1,074,036 |
Basic Shares | 213,637 | 164,043 | 140,433 | 123,035 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.52 |
2026-03-31 | -$0.76 |
2025-12-31 | -$1.54 |
2025-09-30 | -$1.75 |